The site will expand the company’s global drug development and IT & digital capabilities
Bristol Myers Squibb has announced the official opening of a new facility in Hyderabad. The site will expand the company’s global drug development and IT & digital capabilities and is expected to be home to over 1,500 employees. The company has invested over $100 million in the creation of this cutting-edge facility.
The facility was officially opened in the presence of the Minister for Industries & Information Technology of Telangana, D Sridhar Babu. Dr Christopher Boerner, Ph.D., Chief Executive Officer, Bristol Myers Squibb and Greg Meyers, Chief Digital & Technology Officer, Bristol Myers Squibb, as well as several members of the Bristol Myers Squibb global and Hyderabad leadership teams were present at the ribbon cutting event.
Attending the site opening, Sridhar Babu, said, “I am delighted to celebrate the opening of Bristol Myers Squibb’s site in Hyderabad. This marks an important milestone and investment in our vibrant community, offering opportunities for our rich talent pool here to work at the forefront of science and innovation. I am proud of this strategic partnership with Bristol Myers Squibb, which brings new R&D and IT capabilities to Telangana. We have a wealth of remarkable talent in Telangana who will be able to contribute to important and impactful work at Bristol Myers Squibb. We are looking forward to our continued collaboration.”
Boerner said, “Our new innovation hub in Hyderabad will accelerate drug development and enhance our digital capabilities. This investment also enables us to further diversify our global workforce by adding world-class local talent and strengthening our ability to positively impact patients everywhere.”
“We are grateful for the ongoing collaboration with the Government of Telangana and are committed to working with them and supporting the local community as we continue to grow our company presence in India” he added.